Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$12.46 - $15.48 $3,600 - $4,473
289 Added 10.51%
3,038 $38,000
Q1 2022

Mar 30, 2023

SELL
$6.87 - $11.11 $56,842 - $91,924
-8,274 Reduced 75.06%
2,749 $25,000
Q1 2022

May 12, 2022

SELL
$6.87 - $11.11 $56,842 - $91,924
-8,274 Reduced 75.06%
2,749 $25,000
Q4 2021

Jun 21, 2023

BUY
$7.7 - $37.13 $63,709 - $307,213
8,274 Added 300.98%
11,023 $107,000
Q4 2021

Mar 30, 2023

BUY
$7.7 - $37.13 $962 - $4,641
125 Added 1.15%
11,023 $107,000
Q4 2021

Feb 15, 2022

BUY
$7.7 - $37.13 $962 - $4,641
125 Added 1.15%
11,023 $108,000
Q3 2021

Jun 21, 2023

BUY
$26.46 - $37.15 $215,622 - $302,735
8,149 Added 296.44%
10,898 $370,000
Q2 2021

Jun 21, 2023

BUY
$32.73 - $47.95 $266,716 - $390,744
8,149 Added 296.44%
10,898 $398,000
Q2 2021

Mar 30, 2023

BUY
$32.73 - $47.95 $17,674 - $25,893
540 Added 5.21%
10,898 $398,000
Q2 2021

Aug 16, 2021

BUY
$32.73 - $47.95 $356,364 - $522,079
10,888 Added 108880.0%
10,898 $399,000
Q1 2021

Jun 26, 2023

BUY
$40.39 - $56.73 $307,327 - $431,658
7,609 Added 276.79%
10,358 $464 Million
Q1 2021

Mar 30, 2023

SELL
$40.39 - $56.73 $12,722 - $17,869
-315 Reduced 2.95%
10,358 $464,000
Q1 2021

May 14, 2021

SELL
$40.39 - $56.73 $430,678 - $604,911
-10,663 Reduced 99.91%
10 $464,000
Q4 2020

Jun 22, 2023

BUY
$51.77 - $66.18 $410,225 - $524,410
7,924 Added 288.25%
10,673 $609,000
Q4 2020

Mar 30, 2023

SELL
$51.77 - $66.18 $40,846 - $52,216
-789 Reduced 6.88%
10,673 $609,000
Q4 2020

Feb 16, 2021

SELL
$51.77 - $66.18 $40,846 - $52,216
-789 Reduced 6.88%
10,673 $609,000
Q3 2020

Jun 26, 2023

BUY
$43.8 - $58.16 $381,629 - $506,748
8,713 Added 316.95%
11,462 $588,000
Q2 2020

Jun 26, 2023

BUY
$37.05 - $65.03 $322,816 - $566,606
8,713 Added 316.95%
11,462 $684,000
Q2 2020

Mar 30, 2023

BUY
$37.05 - $65.03 $186,509 - $327,361
5,034 Added 78.31%
11,462 $684,000
Q2 2020

Aug 14, 2020

BUY
$37.05 - $65.03 $186,509 - $327,361
5,034 Added 78.31%
11,462 $685,000
Q1 2020

Jul 12, 2023

BUY
$33.63 - $69.4 $123,724 - $255,322
3,679 Added 133.83%
6,428 $264,000
Q1 2020

Mar 30, 2023

BUY
$33.63 - $69.4 $8,003 - $16,517
238 Added 3.84%
6,428 $264,000
Q1 2020

May 15, 2020

BUY
$33.63 - $69.4 $8,003 - $16,517
238 Added 3.84%
6,428 $265,000
Q4 2019

Jul 12, 2023

BUY
$31.7 - $69.93 $109,079 - $240,629
3,441 Added 125.17%
6,190 $385,000
Q4 2019

Mar 30, 2023

BUY
$31.7 - $69.93 $14,899 - $32,867
470 Added 8.22%
6,190 $385,000
Q4 2019

Feb 14, 2020

BUY
$31.7 - $69.93 $14,899 - $32,867
470 Added 8.22%
6,190 $385,000
Q3 2019

Jul 12, 2023

BUY
$19.95 - $38.85 $59,271 - $115,423
2,971 Added 108.08%
5,720 $194,000
Q3 2019

Mar 30, 2023

BUY
$19.95 - $38.85 $59,271 - $115,423
2,971 Added 108.08%
5,720 $194,000
Q3 2019

Nov 14, 2019

BUY
$19.95 - $38.85 $114,114 - $222,222
5,720 New
5,720 $194,000
Q2 2019

Jul 12, 2023

SELL
$21.05 - $26.21 $32,753 - $40,782
-1,556 Reduced 56.6%
1,193 $26.9 Million
Q4 2018

Feb 14, 2019

SELL
$19.08 - $36.14 $11,562 - $21,900
-606 Closed
0 $0
Q3 2018

Jul 13, 2023

BUY
$33.57 - $42.1 $570 - $715
17 Added 0.62%
2,766 $107 Million
Q3 2018

Nov 14, 2018

BUY
$33.57 - $42.1 $20,343 - $25,512
606 New
606 $23,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.